The market for anti-obesity drugs in India has seen exponential growth, swelling from ₹137 crore in November 2020 to ₹535 crore in November 2024 The market for anti-obesity drugs in India has seen exponential growth, swelling from ₹137 crore in November 2020 to ₹535 crore in November 2024 Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
Obesity and diabetes management drug launched in India by American pharma company Eli Lilly
